1
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions
Condition(s):BioequivalenceLast Updated:May 25, 2011Completed
Ovcon® 35 Fe: 7 Clinical Trials
Hide Studies Not Open or Pending
2
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions
Condition(s):HealthyLast Updated:May 30, 2011Completed
3
Study of Loestrin 24(24 Days of “Real” Pills) Fe Versus Loestrin 1/20 (21 “Real” Pills)
Condition(s):Pelvic Pain; Headaches; EmotionalLast Updated:July 25, 2011Completed
4
Oral Contraceptive (OC) Progestin Dose and Breast Proliferation
Condition(s):Oral ContraceptiveLast Updated:February 23, 2018Completed
5
Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation
Condition(s):Oral ContraceptiveLast Updated:September 10, 2014Unknown status
6
Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)
Condition(s):ContraceptionLast Updated:August 31, 2018Terminated
7
Study Of Lybrel In Relation To Venous Thromboembolism
Condition(s):Venous Thrombosis; Pulmonary Embolism; Sinus Thrombosis, IntracranialLast Updated:July 17, 2013Completed